Literature DB >> 11204822

Cytokine delivery and tissue engineering.

S J Lee1.   

Abstract

Tissue engineering has been applied to various tissues, and particularly significant progress has been made in the areas of skin, cartilage, and bone regeneration. Inclusion of bioactive factors into the synthetic scaffolds has been suggested as one of the possible tissue engineering strategies. The growth factors are polypeptides that transmit signals to modulate cellular activities. They have short half-lives, for example, platelet-derived growth factor (PDGF), isolated from platelets, has a half life of less than 2 minutes when injected intravenously. Extended biological activity and the controlled release of growth factor are achieved by incorporating growth factor into the polymeric device. This review will focus on growth factor delivery for tissue engineering. Particular examples will be given whereby growth factors are delivered from a tissue-engineered device to facilitate wound healing and tissue repair.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11204822     DOI: 10.3349/ymj.2000.41.6.704

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  20 in total

1.  Gene delivery in tissue engineering: a photopolymer platform to coencapsulate cells and plasmid DNA.

Authors:  Deborah J Quick; Kristi S Anseth
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

Review 2.  Surface treatments and roughness properties of Ti-based biomaterials.

Authors:  Andrea Bagno; Carlo Di Bello
Journal:  J Mater Sci Mater Med       Date:  2004-09       Impact factor: 3.896

3.  siRNA nanoparticle functionalization of nanostructured scaffolds enables controlled multilineage differentiation of stem cells.

Authors:  Morten Ø Andersen; Jens V Nygaard; Jorge S Burns; Merete K Raarup; Jens R Nyengaard; Cody Bünger; Flemming Besenbacher; Kenneth A Howard; Moustapha Kassem; Jørgen Kjems
Journal:  Mol Ther       Date:  2010-08-31       Impact factor: 11.454

4.  Nano-fibrous scaffold for controlled delivery of recombinant human PDGF-BB.

Authors:  Guobao Wei; Qiming Jin; William V Giannobile; Peter X Ma
Journal:  J Control Release       Date:  2006-03-03       Impact factor: 9.776

5.  Functional restoration of critically sized segmental defects with bone morphogenetic protein-2 and heparin treatment.

Authors:  Mela R Johnson; Joel D Boerckel; Kenneth M Dupont; Robert E Guldberg
Journal:  Clin Orthop Relat Res       Date:  2011-11       Impact factor: 4.176

6.  Inkjet-based biopatterning of bone morphogenetic protein-2 to spatially control calvarial bone formation.

Authors:  Gregory M Cooper; Eric D Miller; Gary E Decesare; Arvydas Usas; Emily L Lensie; Michael R Bykowski; Johnny Huard; Lee E Weiss; Joseph E Losee; Phil G Campbell
Journal:  Tissue Eng Part A       Date:  2010-05       Impact factor: 3.845

7.  Sustained release of BMP-2 in a lipid-based microtube vehicle.

Authors:  Mela R Johnson; Hyun-Jung Lee; Ravi V Bellamkonda; Robert E Guldberg
Journal:  Acta Biomater       Date:  2008-09-18       Impact factor: 8.947

Review 8.  Microcomputed tomography characterization of neovascularization in bone tissue engineering applications.

Authors:  Simon Young; James D Kretlow; Charles Nguyen; Alex G Bashoura; L Scott Baggett; John A Jansen; Mark Wong; Antonios G Mikos
Journal:  Tissue Eng Part B Rev       Date:  2008-09       Impact factor: 6.389

Review 9.  Biomaterial-guided delivery of gene vectors for targeted articular cartilage repair.

Authors:  Magali Cucchiarini; Henning Madry
Journal:  Nat Rev Rheumatol       Date:  2019-01       Impact factor: 20.543

10.  Effects of polycaprolactone-tricalcium phosphate, recombinant human bone morphogenetic protein-2 and dog mesenchymal stem cells on bone formation: pilot study in dogs.

Authors:  Sun-Jong Kim; Myung-Rae Kim; Jin-Sub Oh; Inho Han; Sang-Wan Shin
Journal:  Yonsei Med J       Date:  2009-12-18       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.